The transfusion-associated transmission of parvovirus B19

The transfusion-associated transmission of parvovirus B19 Alberta Azzi, Massirno Morfini and Pier Mannuccio Mannucci HE HUMAN PARVOVIRUS B19 is a member of the family Parvoviridae (subfamily: Parvovirinae) that recently, because of its tropism for red blood cell progenitors, has been placed in the genus Erythrovirus. 1 Most parr are common animal pathogens, such as feline panleukopenia parvovirus and canine parvovirus. However, animal parvoviruses are not transmissible to humans and parvovirus B19 is the only known human-pathogenic parvovirus. 2 B 19 virus was discovered by chance by Y.E. Cossart and her associates 3 in 1975, while screening plasma of blood donors for hepatitis B antigen. It was first named "serum parvovirus-like virus" and then human parvovirus B 19, from the number of plasma samples in which it was found for the first time) The virus was independently described also in France and Japan, where it was called Auriltac or Nakatani antigen, respectively. Thus, B 19 virus was initially detected in asymptomatic individuals, and asymptomatic B19 infections occurs in 20% to 30% of individuals: It took several years to prove the causative role of B 19 virus in human diseases. Now B19 virus is known to be responsible for a variety of clinical manifestations, which depend http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Transfusion Medicine Reviews Elsevier

The transfusion-associated transmission of parvovirus B19

11 pages
Read Article

Loading next page...
 
/lp/elsevier/the-transfusion-associated-transmission-of-parvovirus-b19-OZa0UZa5x8
Publisher site
See Article on Publisher Site

Abstract

Alberta Azzi, Massirno Morfini and Pier Mannuccio Mannucci HE HUMAN PARVOVIRUS B19 is a member of the family Parvoviridae (subfamily: Parvovirinae) that recently, because of its tropism for red blood cell progenitors, has been placed in the genus Erythrovirus. 1 Most parr are common animal pathogens, such as feline panleukopenia parvovirus and canine parvovirus. However, animal parvoviruses are not transmissible to humans and parvovirus B19 is the only known human-pathogenic parvovirus. 2 B 19 virus was discovered by chance by Y.E. Cossart and her associates 3 in 1975, while screening plasma of blood donors for hepatitis B antigen. It was first named "serum parvovirus-like virus" and then human parvovirus B 19, from the number of plasma samples in which it was found for the first time) The virus was independently described also in France and Japan, where it was called Auriltac or Nakatani antigen, respectively. Thus, B 19 virus was initially detected in asymptomatic individuals, and asymptomatic B19 infections occurs in 20% to 30% of individuals: It took several years to prove the causative role of B 19 virus in human diseases. Now B19 virus is known to be responsible for a variety of clinical manifestations, which depend

Journal

Transfusion Medicine Reviews – Elsevier

Published: Jul 1, 1999

References

  • Virus Taxonomy, classification and nomenclature of viruses
    International Committee on Taxonomy of Viruses
  • The biology and pathogenicity of autonomous parvoviruses,
    Siegl, G
  • Parvovirus-like particles in human sera
    Cossart, YE; Field, AM; Cant, B
  • Antibodies to the non structural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis
    Von Poblotzki, A; Hemauer, A; Gigler, A
  • Erythrocyte P antigen-cellular receptor for B19 virus
    Brown, KE; Anderson, SM; Young, NS
  • Molecular, cellular and clinical aspects of Parvovirus B19 infection
    Brown, KE; Young, NS; Liu, JM
  • Low prevalence of antibody to human parvovirus B19 in Singapore
    Matsunaga, Y; Goh, KT; Utagawa, E
  • Parvovirus infections and hypoplastic crisis in sickle-cell anemia
    Pattison, JR; Jones, SE; Hodgson, J
  • Hematologic and hematopoietic consequences of parvovirus B19 infection
    Young, N
  • An outbreak of erythema infectiosum associate with human parvovirus infection
    Anderson, MJ; Lewis, E; Kidd, IM
  • Human parvovirusassociated arthritis: A clinical and laboratory description
    Reid, DM; Reid, TMS; Brown, T
  • Clinical manifestations of human parvovirus B19 in adults
    Woolf, AD; Campion, GV; Chishick, A
  • Human parvovirus infection in early rheumatoid and inflammatory arthritis
    Cohen, BJ; Buckley, MM; Clewley, JP
  • Human parvovirus B19 as a causative agent for rheumatoid arthritis
    Takahashi, Y; Murai, C; Munakata, Y
  • Serologically proved intrauterine infection with parvovirus
    Knott, PD; Wepley, GAC; Anderson, MJ
  • Prospective study of human parvovirus (B19) infection in pregnancy
    Public Health Laboratory Service Working Party on Fifth Disease
  • Chronic bone marrow failure due to persistent B19 parvovirus infection
    Kurtzman, GJ; Ozawa, K; Cohen, B
  • Aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia
    Azzi, A; Macchia, PA; Favre, C
  • Persistent parvovirus B19 infections with different clinical outcome in renal transplant recipients: diagnostic relevance of PCR and of quantification of B19 DNa in sera
    Azzi, A; Zakrzewska, K; Bertoni, E
    Bookmark
  • Persistent parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause anemia in AIDS
    Frickofen, N; Abkowitz, JL; Safford, M
  • Persistent B19 parvovirus infections in hemophilic HIV-1 infected patients
    Musiani, M; Zerbini, M; Gentilomi, G
    Bookmark
  • Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
    Soderlund, M; Von Essen, R; Haapasaari, U
  • Evidence of persistence of human parvovirus B19 DNA in bone marrow
    Cassinotti, P; Burtonoboy, G; Fopp, M
    Bookmark
  • Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: Evidence for B19 virus persistence
    Foto, F; Saag, KG; Howard, EJ
  • Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient
    Cassinotti, P; Schultze, D; Schlageter, P
  • Human parvovirus B19 encephalopathy
    Watanabe, T; Satoh, M; Oda, Y
    Bookmark
  • Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: Report of a case
    Martinelli, M; Azzi, A; Buffini, G
  • Active or recent parvovirus B19 infection in children with Kawasaki disease
    Nigro, G; Zerbini, M; Krzysztofiak, A
  • Henoch Schonlein purpura and human parvovirus infection
    Lefrere, JJ; Courouce, AM; Soulier, JP
  • Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia
    Langnas, AN; Markin, RS; Cattral, MS
    Bookmark
  • Myocarditis caused by parvovirus
    Saint-Martin, J; Choulot, JJ; Bonnaud, E
  • Possible induction of systemiuc lupus erythematosus by human parvovirus
    Cope, AP; Jones, A; Brozovic, M
  • Hypoplastic anemia in hemophiliac first infused with a solvent-detergent treated factor VIII concentrate
    Morfini, M; Azzi, A; Zakrzewska, K
    Bookmark
  • Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate
    Lyon, DJ; Chapman, CS; Matin, C
  • Parvovirus B19 qiescence during the course of human immunodeficiency virus infection in persons with hemophilia
    Goedert, JJ; Erdman, DD; Konkle, BA
  • Severe parvovirus B19 infection in an immunocompetent child with hemophilia A
    Coumau, E; Peynet, J; Harzic, M
  • Life-threatening human parvovirus B19 infection in immunocompetent hemophiliac
    Yee, TT; Lee, CA; Pasi, KJ
  • Experimental parvoviral infection in man
    Anderson, MJ; Cohen, B; Meyers, RL
  • Persistent B19 parvovirus infection as a cause of severe anaemia in children with acute lymphocytic leukemia
    Kurtzman, GJ; Cohen, B; Meyers, P
  • Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells
    Moffatt, S; Yaegashi, N; Tada, K
  • Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG
    Ferguson, M; Walker, D; Cohen, B
  • Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: Characterization by PCR and B-cell molecular immunology
    Söderlund, M; Ruutu, P; Ruutu, T
  • Detection of B19 parvovirus infections by a dot blot hybridization assay using a digoxigenin-labelled probe
    Azzi, A; Zakrzewska, K; Gentilomi, G
  • Detection of parvovirus B19 DNA in bone marrow cells by chemioluminescence in situ hybridization
    Musiani, M; Roda, A; Zerbini, M
  • Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction
    McOmish, F; Yap, PL; Jordan, A
  • Collaborative study to assess the suitability of a proposed working reagent for human parvovirus B19 DNA detection in plasma pools by gene amplification techniques. B19 Collaborative Study Group
    Saldanha, J; Minor, P
  • Transfusion-transmitted human parvovirus, B19 infection in a thalassemic patients
    Zanella, A; Rossi, F; Cesana, C
    Bookmark
  • Chronic anemia due to parvovirus infection in a bone marrow transplant patient after platelet transfusion
    Cohen, BJ; Beard, S; Knowles, WA
    Bookmark
  • Human parvovirus B19: Prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients
    Jordan, J; Tiangco, B; Kiss, J
  • Incidence of human parovirus B19 DNA detection in blood donors
    Yoto, Y; Kudoh, T; Haseyama, K
  • Transmission, of serum parvovirus-like virus by clotting-factor concentrates
    Mortimer, PP; Luban, NLC; Kelleher, JF
  • Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates
    Bartolomei Corsi, O; Azzi, A; Morfini, M
    Bookmark
  • Transmission of human parvovirus B19 by coagulation factor concentrates
    Williams, MD; Cohen, BJ; Beddall, AC
    Bookmark
  • Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs
    Grobe-Bley, A; Eis-Hubinger, AM; Kaiser, R
  • Prevalence of antibodies against parvovirus B19 in Norwegian with congenital coagulations factor defects treated with plasma products from small donor
    Rollag, H; Patou, G; Pattison, JR
  • Prevalence of antibodies to parvovirus B19 in selected groups of patients and healthy individuals
    Schwartz, TF; Hottentrager, B; Roggendorf, M
  • Parvovirus, B19 antibodies in patients with hemophilia A
    Peerlinck, K; Goubau, P; Reybrouck, R
  • The prevalence of antibody to parvovirus B19 in hemophiliacs and in the general population
    Eis-Hubinger, AM; Oldenburg, J; Brackmann, HH
  • Efficacy of high temperature dry heat in inactivating parvovirus
    Flores, G; Juarez, JC; Montoro, JB
    Bookmark
  • Transmission of human parvovirus B19 by plasma derived factor VIII concentrates
    Laurian, Y
  • Parvovirus B19 infection in patients with hemophilia
    Ragni, MV; Koch, WC; Jordan, JA
    Bookmark
  • Hugh prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients
    Mauser-Bunschoten, EP; Zaaijer, HL; van Drimmelen, AA
  • Parvovirus B19 infection in patients with congenital blood coagulation disorders
    Aguilar, FC; Lucia Cuesta, JF; Ferrer Torres, J
  • Recommendations of International Committee on Thrombosis and Haemostasis (ICTH), Subcommittees on Factor VIII and factor IX on virus safety studies in hemophiliacs, Miani, FL
  • Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates
    Mannucci, PM; Colombo, M
  • Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VII, concentrates
    Azzi, A; Ciappi, S; Zakrzewska, K
  • Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: Parallel evaluation of the other markers for lipid-neveloped and non-lipid enveloped viruses
    Mariani, G; Di Paolantonio, T; Baklaya, R
  • Mannucci PM for Medical-Scientific Conmitte, Fodazione dell'Emofilia: Outbreak of hepatitis A among Italian patients with haemophilia
  • Acute hepatitis A in haemophiliacs
    Gerritzen, A; Schneweis, KE; Brackmann, HH
  • Acute hepatitis A in patients with haemophilia A
    Peerlink, K; Vermylen, J
  • Cloming factors and hepatitis A
    Temperly, IJ; Cotter, KP; Walsh, TJ
  • Conmened solvent-detergent and 100°C (boiling) sterilizing dry-heatratment of factor VIII concentrates to assure sterility
    Rubenstein, AI; Rubenstein, DB; Coughlin, J
  • Dans mission of parvovirus B19 by coagulation factor coecentrates exposed to 100°C heat after lyophilization
    Satagostino, E; Mannucci, PM; Gringeri, A
  • Parvovirus B19 and blood products
    Prowse, CV
  • Inactivation of lipid-enveloped and non-lipid-enveloped model viruses in nemal human plasma by crosslinked starch-iodine
    Highsmit, FA; Xue, H; Caple, M
  • Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments
    Ristol, P; Gensana, M; Fernandez, J
  • Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates
    Hart, HF; Hart, WG; Crossley, J
  • Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates
    Burnouf-Raidosevich, M; Appourchaux, P; Huart, JJ
  • Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction
    Zakrzwska, K; Azzi, A; Patou, G
  • B19 parvovirus DNA in solvent detergent treated antihemophilia concentrates
    Lefrere, JJ; Mariotti, M; Thauvin, M
  • Parvovirus B19 is frequently present in recombinant coagulation factor VIII products (letter)
    Eis-Hubinger, AM; Sasowski, U; Brackmann, HH
  • A multicenter pharmacosurveillance study for the evaluation of the efficacy and safety of recombinant factor VIII in the treatment of patients with hemophilia A
    Aygoren-Pursun, E; Scharrer, I
  • Pasteurization of antihemophilic factor and model virus inactivation studies
    Ng, PK; Dobkin, MB
  • Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: Implications for efficiency and consistency of remocal of B19 DNA during manufacture
    Saldanha, J; Minor, P
  • Alburmin batches and B19 parvovirus DNA
    Lefrere, JJ; Mariotti, M; De la Croix, I

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial